Coya Therapeutics Inc (COYA) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Coya Therapeutics, Inc. (COYA) kompaniyasining ALS kasalligini davolash bo'yicha strategik ittifoqlari aktivning tebranishlarini ta'kidlaydi. Tarixiy uzoq muddatli qarzdorlikning kapitalga nisbati ushbu tebranishlarni vizuallashtiradi, bunda 0.00 qiymati ushbu holatni aks ettiradi. Joriy pul oqimlarining yo'qligi sababli tashqi moliyalashtirishga tayanish, shuningdek, kelajakdagi loyihalar portfelini mustahkamlash uchun Altsgeymer kasalligiga qarshi innovatsion Treg terapiyalarini ishlab chiqish orqali xavflarni kamaytirish ta'minlanmoqda.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_COYA_-_Coya-Therapeutics-Inc._-_Long-Term-Debt-to-Equity-Ratio "COYA - Coya Uzoq muddatli qarzning kapitalga nisbati 28.04.2023 - 01.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Coya Therapeutics Inc (COYA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Coya Therapeutics, Inc.|COYA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Coya|COYA - Kompaniya qarzlari|Balans qiymatiga qarzlar Coya Therapeutics, Inc.|COYA - Kompaniyaning uzoq muddatli majburiyatlari|Qisqa muddatli qarz Coya Therapeutics|Tezkor likvidlik koeffitsiyenti coyatherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:COYA (coyatherapeutics.com)
Ushbu ko'rsatkich bir yildan ortiq muddatga ega majburiyatlarni kapitalning bozor qiymati bilan solishtirish orqali moliyaviy leveraj barqarorligini baholaydi. Uzoq muddatli qarzdorlikning kapitalga nisbati kompaniyaning tashqi qarzlarga qanchalik bog'liqligini aniqlaydi. Hisob-kitoblar joriy bozor kapitalizatsiyasiga asoslangan bo'lib, bu defolt xavfini real vaqt rejimida baholash imkonini beradi. Coya Therapeutics, Inc. (COYA) uchun qarz yuklamasining pastligi juda muhimdir, chunki T-hujayralar terapiyasini ishlab chiqish patent tozaligi va FDA tasdig'iga bog'liq. Bu qimmatga tushadigan klinik sinovlar davrida moliyaviy bosimni minimallashtiradi.
Raqobatdosh kompaniyalar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Trevi Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Praxis Corp (PRAX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|CBLL - Uzoq muddatli qarzning kapitalga nisbati|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER (Omeros Corp.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Cassava Sciences Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ASRT|VTGN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Ovid Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acumenpharm.com ABOS|CRVO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Alterity Therapeutics - Uzoq muddatli kreditlarning kapitalga nisbati|CLNN: Uzoq muddatli qarzning kapitalga nisbati|PEPG - Uzoq muddatli qarzdorlikning kapitalga nisbati|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati relmada.com (RLMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio (ANVS)|Uzoq muddatli qarzdorlikning kapitalga nisbati gracetx.com|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KLTO|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revivapharma.com RVPH|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NRXS|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio Corp (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (Neuphoria Therapeutics Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cyclerion Therapeutics|PTIX (protagenic.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Avenue Therapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevena Inc. TRVN|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CERE: Uzoq muddatli qarzning o'z kapitaliga nisbati